SS
Shivnandan Saini
About Shivnandan Saini
Shivnandan Saini has 11 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Envanto Corporate Business Solutions Llp. Formerly with 4 companies, such as Zenesta Lifescience Private Limited and Lifeway Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Designated Partner | 13 Jan 2024 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Zenesta Lifescience Private Limited
U74999UP2018PTC105826
|
Director | 29 Jun 2018 | 2018 | Active |
Lifeway Pharmaceuticals Private Limited
U51101UP2013PTC057463
|
Director | 26 Aug 2014 | 2013 | Active |
Diamond Comics Pvt Ltd
U74899DL1982PTC014478
|
Additional Director | 15 Jan 2023 | 1982 | Active |
Saar Medicare Private Limited
U74999UP2016PTC088320
|
Additional Director | 20 Oct 2019 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shivnandan Saini
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shivnandan Saini
Shivnandan Saini has 11 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Envanto Corporate Business Solutions Llp. Formerly with 4 companies, such as Zenesta Lifescience Private Limited and Lifeway Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Shivnandan Saini is associated with 1 company as Designated Partner.
Shivnandan Saini has expertise in General Business.
Shivnandan Saini has 11 years in corporate governance.